Branding Marketing Pharma Companies Pharmacy 
World of DTC Marketing
OCTOBER 4, 2021
Earlier this year, I was asked by a client to write a position paper on using Facebook for the DTC marketing of an oncology product. A year ago, Facebook was making a hard charge to get the pharma business. TV will still be the first choice for many DTC marketers, but digital is increasing even though 50% of that money is wasted.
World of DTC Marketing
JUNE 22, 2022
PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. Generic drugs versus branded is also a considerable expense. If pharmacies try to fill those generic prescriptions, the claims are rejected.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 8, 2021
The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.
World of DTC Marketing
JULY 27, 2022
Pharma companies have very little control over patients’ prices for their Rxs. A drug’s out-of-pocket cost is primarily the result of decisions made by insurance companies and pharmacy benefit managers (PBMs). Let’s take a step back for a minute.
Pharmaceutical Technology
JULY 15, 2022
Nothing epitomises market failures more than the cost of insulin,” Newsom said in a video posted on Twitter. Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk. Industry split over the pricing issues.
Pharmaceutical Technology
MARCH 24, 2023
Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. AbbVie had reached settlement agreements with the biosimilar manufacturers to keep the biosimilars off the US market until 2023.
World of DTC Marketing
FEBRUARY 21, 2022
A new study estimates the causal effects of coupons for branded drugs without bioequivalent generics using variation in coupon introductions over time and comparing differential responses across enrollees in commercial and Medicare Advantage plans. spending annually. ” More checks from PhRMA to politicians are coming up.
Expert insights. Personalized for you.
224 
Let's personalize your content